Skip to Main Content
Skip Nav Destination

Improving Access to High-Value, High-Cost Medicines: The Use of Subscription Models to Treat Hepatitis C Using Direct-Acting Antivirals in the United States

J Health Polit Policy Law (2022) 47 (6): 691–708.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Julia M. Y. Pian
  • Nana Owusu
  • Julia Vitarello
  • Winston X. Yan
  • Andrew W. Lo
  • Timothy W. Yu
Nature Medicine (2024) 30 (7): 1816.
  • Nicola Schiano Moriello
  • Biagio Pinchera
  • Ivan Gentile
Expert Review of Anti-infective Therapy (2024) 22 (4): 139.
  • Grace Hampson
  • Lotte Steuten
Expert Review of Pharmacoeconomics & Outcomes Research (2024) 24 (1): 1.
  • Johan L Dellgren
  • Govind Persad
  • Ezekiel J Emanuel
The Lancet (2024) 404 (10455): 902.
  • Andrew H. Talal
  • Arpan Dharia
  • Shashi N. Kapadia
  • Gia L. Tyson
  • Susan Birch
  • Judy Zerzan-Thul
  • Donna Sullivan
  • Elizabeth Britton
  • Elaine Wethington
  • Christopher J. Gonzalez
  • Mary Fliss
  • Brandon Mizroch
  • Frederic McCall
  • Audrey R. Lloyd
  • Martin F. Shapiro
  • Ricardo Franco
Journal of Public Health Management and Practice (2024) 30 (2): 208.
  • J.I. Tsui
  • A.J. Gojic
  • K.A. Pierce
  • E.L. Tung
  • N.C. Connolly
  • A.C. Radick
  • R.R. Hunt
  • R. Sandvold
  • K. Taber
  • M. Ninburg
  • R.H. Kubiniec
  • J.D. Scott
  • R.N. Hansen
  • J.D. Stekler
  • E.J. Austin
  • E.C. Williams
  • S.N. Glick
Drug and Alcohol Dependence Reports (2024) 10: 100213.
  • Laura Hawks
  • Emily Wang
JAMA Health Forum (2023) 4 (4): e230167.
Close Modal

or Create an Account

Close Modal
Close Modal